RNMT and breast cancer: Strengthening the link between PIK3CA mutations and RNMT inhibition, breast cancer cell lines and mammary epithelial cells, which were insensitive to RNMT siRNA transfection, could be rendered sensitive by the expression of PIK3CA oncogenic mutants (figures 4 and 5).